- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06431464
Tattoo Particles: Picosecond Laser Versus Nanosecond Laser
May 27, 2024 updated by: Lynhda Nguyen, Universitätsklinikum Hamburg-Eppendorf
In Vivo Analysis of Tattoo Particles After Picosecond Laser Compared to Nanosecond Laser
- For treating unwanted tattoos, the gold standard treatment is a nanosecond or picosecond laser.
However, comparative microscopic analysis is limited.
Therefore, the aim of the present study is to analysis morphological changes of tattoo particles and surrounding tissue in human skin.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lynhda Nguyen, Dr. med.
- Phone Number: +49 (0) 7410-0
- Email: l.ngyuen@uke.de
Study Locations
-
-
-
Hamburg, Germany, 20251
- Recruiting
- University Medical Center Hamburg-Eppendorf
-
Contact:
- L Nguyen, Dr. med.
- Phone Number: +49 (0)40-74100
- Email: l.nguyen@uke.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
- healthy patients who plan a laser treatment of their unwanted tattoo/ tattoos at our department
Description
Inclusion Criteria:
- healthy patients who plan a laser treatment of their unwanted tattoo/ tattoos at our department
Exclusion Criteria:
- laser pretreatment of their tattoos to be treated
- pregnancy, breast feeding
- open wound on the area to be treated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Nanosecond laser
Patients with unwanted tattoos who plan a nanosecond laser treatment will be recruited for measurements using a multiphoton-tomography system.
|
Patients with unwanted tattoos who plan a laser treatment will be recruited for measurements using a multiphoton-tomography system.
These are scheduled 6 weeks and 12 weeks post-treatment.
|
|
Picosecond laser
Patients with unwanted tattoos who plan a picosecond laser treatment will be recruited for measurements using a multiphoton-tomography system.
|
Patients with unwanted tattoos who plan a laser treatment will be recruited for measurements using a multiphoton-tomography system.
These are scheduled 6 weeks and 12 weeks post-treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Size of intercellular spaces
Time Frame: 6 weeks and 12 weeks post-treatment
|
Size of intercellular spaces after picosecond or nanosecond laser treatment.
|
6 weeks and 12 weeks post-treatment
|
|
Size of keratinocytes
Time Frame: 6 weeks and 12 weeks post-treatment
|
Size of keratinocytes after picosecond or nanosecond laser treatment.
|
6 weeks and 12 weeks post-treatment
|
|
Size of tattoo particles
Time Frame: 6 weeks and 12 weeks post-treatment
|
Size of tattoo particles after picosecond or nanosecond laser treatment.
|
6 weeks and 12 weeks post-treatment
|
|
Distribution of tattoo particles
Time Frame: 6 weeks and 12 weeks post-treatment
|
Distribution though the epidermal and dermal layers after picosecond or nanosecond laser treatment.
|
6 weeks and 12 weeks post-treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2024
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
July 31, 2024
Study Registration Dates
First Submitted
February 19, 2024
First Submitted That Met QC Criteria
May 27, 2024
First Posted (Actual)
May 28, 2024
Study Record Updates
Last Update Posted (Actual)
May 28, 2024
Last Update Submitted That Met QC Criteria
May 27, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 02-24
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tattoo; Pigmentation
-
Ephemeral Solutions Inc.CompletedTattoo; PigmentationUnited States
-
Syneron MedicalUnknownTattoo; PigmentationUnited States
-
Centre Hospitalier Universitaire de NiceCompletedTattoo; PigmentationFrance
-
Henry Ford Health SystemEphemeral Solutions Inc.CompletedCancer, Treatment-Related | Tattoo; PigmentationUnited States
-
LUTRONIC CorporationTerminatedMelasma | Tattoo; Pigmentation | Benign Pigmented LesionUnited States
-
Massachusetts General HospitalCompletedTattoo Removal | TattooUnited States
-
University Hospitals of Derby and Burton NHS Foundation...CompletedBreast Cancer | Sentinel Lymph Node | Tattoo; Pigmentation | Axilla; BreastUnited Kingdom
-
Cutera Inc.CompletedTattoo RemovalUnited States
-
Cutera Inc.Completed
-
SolitonMedSource LLCCompleted
Clinical Trials on nanosecond laser treatment + measurement with a multiphoton tomography system
-
Wroclaw Medical UniversityCompletedCaries,Dental | Aerosol DiseasePoland
-
National Taiwan University HospitalBRIDGECON CO,.LTD.CompletedLaser | PeriorbitalTaiwan
-
University Hospital, GhentUniversity GhentCompletedPost-operative PainBelgium
-
Medical University of ViennaCompletedMacular Edema | Proliferative Diabetic RetinopathyAustria
-
Henry Ford Health SystemCompleted
-
Phenox GmbHRecruitingStenosis | Intracranial Aneurysms | Pseudoaneurysm | Perforation | Saccular and Fusiform Aneurysms | Vascular Dissection | Bifurcation Aneurysms | Neurovascular Abnormalties | Wide-neck AneurysmGermany, Switzerland, France, Slovakia, Italy
-
University Hospital, MontpellierUnknownOrthopedic SurgeryFrance
-
University of British ColumbiaChildren's & Women's Health Centre of British ColumbiaCompletedHypotension | Cesarean DeliveryCanada
-
Ankara Universitesi TeknokentCompletedRetinitis Pigmentosa | Cystoid Macular EdemaTurkey
-
University of Turin, ItalyRecruitingGingival Recession, GeneralizedItaly